Flagship Signal Product
The Trial Landscape Does Not Wait. BioAlliance Detects The Signal Before It Reaches ClinicalTrials.gov.
By the time a clinical trial appears on ClinicalTrials.gov, the preferred vendors are already in conversations. The early decisions are made at the abstract stage, at the funding close, at the conference meeting. Trial Signal monitors every signal source simultaneously: conference abstracts, funding closes, partnering activity, protocol amendments, enrollment trends, and phase transitions. Study activity is surfaced before it reaches the market. Your BD team initiates conversations before competitors know the window exists.
The Product
What Trial Signal Is.
Trial Signal is the most comprehensive intelligence product in the Signal Suite. Where other products focus on a single signal type, Trial Signal monitors the complete commercial signal landscape and delivers it as a prioritized, BD-ready intelligence report. Every edition is customized to your geography, therapeutic focus, company size, trial phase, and BD priorities. Your differentiators are framed into every BD note. Your conference calendar is mapped against every target company. Named companies can be included or excluded before the edition is built.
Every Edition
What Every Edition Includes
Getting Started
Four Steps To Your First Edition.
Schedule a 30-minute scoping call. Define your BD priorities: geographies, therapeutic focus, trial phase, company stage, conference calendar, named includes and excludes.
Complete the Trial Signal configuration form. Your specifications become the permanent filters for every edition.
Receive your first edition within 10 to 15 business days of configuration confirmation. BD-ready on day of receipt.
BD Integration Support available as a separate engagement: outreach strategy, messaging development, and pipeline activation.
The Intelligence Standard.
What Every Edition Includes
Trial Readiness Score from 1 to 10 with an urgency band of Immediate, 6 to 12 months, or 12 to 24 months.
Conference Intelligence, The Highest-Value First Contact
Conference Introductions Are The Highest-Value First Contact.
Before building your edition, BioAlliance Strategies maps all relevant upcoming conferences against your target companies. Every target company presenting, exhibiting, or actively engaged at a conference you are attending is flagged as a conference introduction opportunity and prioritized above cold outreach in their engagement sequence. You arrive at every conference with a targeted list of who to meet, what they are working on, and why this week is the right time to introduce yourself.
Speaking Slots
If your team has a confirmed speaking slot, panel, or poster presentation, we flag it in your edition. Every target company attending that event who qualifies under your ICP is identified before you walk in the door.
Conference Calendar Scope
Your next 90 days of confirmed conference attendance. Your 12-month conference calendar. The conferences where your ICP companies present even if you do not currently attend. All mapped. All cross-referenced against your target list.
Edition Customization, Your Specifications Are Hard Filters
Every Edition Is Built Exclusively To Your Configuration.
Geographic Scope
Target specific regulatory markets: FDA, EMA, MHRA, TGA, Health Canada, and more. Regional filters included at no extra cost.
Therapeutic Focus
Oncology, CNS and Neurology, Rare Disease, Cardiometabolic, Immunology, Infectious Disease, or custom therapeutic areas specific to your organization.
Trial Phase
IND prep, Phase I, Phase II, or custom phase targeting. Narrow to the development stage your BD team can most effectively engage.
Company Stage
Seed, Series A, Series B, or custom capital stage filters. Match your ICP exactly.
Named Includes
Specific companies you are already tracking can be included by name. BioAlliance verifies they meet ICP before including.
Named Excludes
Existing clients, active proposals, competitor conflicts, and companies already in your pipeline are excluded before the edition is built. Never a wasted entry.
Your Differentiators
BioAlliance asks for your three strongest differentiators before writing any BD notes. Every note is written in your voice against your competitive position.
Begin In Four Steps.
You Now Know What
The Revenue Infrastructure Diagnostic tells you what to build first so you can use it.
Intelligence You Have
Your CMR Score identifies the structural gaps that determine whether Signal Suite intelligence converts into pipeline or sits unused in a PDF.
Commission Trial Signal
Start Before The Window Closes.
Trial Signal is configured to your market, your therapeutic focus, and your BD priorities before the first edition is built.